A. Kunová

820 total citations
28 papers, 526 citations indexed

About

A. Kunová is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, A. Kunová has authored 28 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in A. Kunová's work include Neutropenia and Cancer Infections (21 papers), Antifungal resistance and susceptibility (10 papers) and Bacterial Identification and Susceptibility Testing (10 papers). A. Kunová is often cited by papers focused on Neutropenia and Cancer Infections (21 papers), Antifungal resistance and susceptibility (10 papers) and Bacterial Identification and Susceptibility Testing (10 papers). A. Kunová collaborates with scholars based in Slovakia, United States and Malaysia. A. Kunová's co-authors include V. Krčméry, J. Trupl, S. Špánik, F Mateička, E. Oravcová, E. Kukučková, Jozef Šufliarský, P. Pichňa, Jurga Laurencikiene and Ľuboš Drgoňa and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Journal of Medical Microbiology.

In The Last Decade

A. Kunová

27 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Kunová Slovakia 13 307 285 137 123 65 28 526
C Perego United States 8 660 2.1× 590 2.1× 121 0.9× 77 0.6× 57 0.9× 10 848
B.A. Oppenheim United Kingdom 10 347 1.1× 242 0.8× 88 0.6× 97 0.8× 28 0.4× 12 477
C. Santini Italy 10 192 0.6× 204 0.7× 65 0.5× 90 0.7× 23 0.4× 28 457
José Luís López-Hontangas Spain 12 366 1.2× 383 1.3× 69 0.5× 54 0.4× 32 0.5× 38 681
E. Kukučková Slovakia 12 197 0.6× 165 0.6× 87 0.6× 88 0.7× 17 0.3× 21 312
E. Biraghi Italy 9 544 1.8× 425 1.5× 99 0.7× 63 0.5× 52 0.8× 10 704
Alice G. Bergman United States 9 300 1.0× 216 0.8× 82 0.6× 154 1.3× 9 0.1× 11 504
Asia Obman United States 6 360 1.2× 426 1.5× 26 0.2× 64 0.5× 62 1.0× 6 592
Essam Girgawy United States 8 401 1.3× 349 1.2× 123 0.9× 66 0.5× 20 0.3× 9 565
Christine Bonnal France 14 243 0.8× 303 1.1× 33 0.2× 103 0.8× 160 2.5× 37 553

Countries citing papers authored by A. Kunová

Since Specialization
Citations

This map shows the geographic impact of A. Kunová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kunová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kunová more than expected).

Fields of papers citing papers by A. Kunová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kunová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kunová. The network helps show where A. Kunová may publish in the future.

Co-authorship network of co-authors of A. Kunová

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kunová. A scholar is included among the top collaborators of A. Kunová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kunová. A. Kunová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krčméry, V., M Mrázová, A. Kunová, et al.. (1999). Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Supportive Care in Cancer. 7(6). 428–431. 25 indexed citations
2.
3.
Mateička, F, et al.. (1999). Invasive infections due to. FEMS Immunology & Medical Microbiology. 23(1). 75–78. 1 indexed citations
4.
Krčméry, V., S. Špánik, A. Kunová, et al.. (1999). NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review. Journal of Chemotherapy. 11(2). 131–136. 7 indexed citations
5.
Krčméry, V., et al.. (1999). Bacteremia Due to CiprofLoxacin-Resistant Pseudomonas Aeruginosain Cancer Patients: Risk Factors for Resistance and Outcome of 25 Episodes. A Case-Control Study. Infectious Diseases in Clinical Practice. 8(3). 158–161. 5 indexed citations
6.
Krčméry, V., et al.. (1999). Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Supportive Care in Cancer. 7(1). 39–43. 80 indexed citations
7.
Krčméry, V., E. Oravcová, S. Špánik, et al.. (1998). Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. Journal of Antimicrobial Chemotherapy. 41(3). 373–380. 82 indexed citations
8.
Špánik, S., Jozef Šufliarský, Jozef Mardiak, et al.. (1998). Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes. Supportive Care in Cancer. 6(3). 291–294. 9 indexed citations
9.
Krčméry, V., et al.. (1998). Bacteremia Due to Multiresistant Gram-Negative Bacilli in Neutropenic Cancer Patients: A Case Controlled Study. Journal of Chemotherapy. 10(4). 320–325. 37 indexed citations
10.
Krčméry, V., S. Špánik, A. Kunová, & J. Trupl. (1997). Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B. Chemotherapy. 43(5). 367–370. 11 indexed citations
11.
Kunová, A., J. Trupl, Zdenka Jesenská, et al.. (1997). Eight-Year Surveillance of Non-Albicans Candida spp . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis. Microbial Drug Resistance. 3(3). 283–287. 11 indexed citations
12.
13.
Špánik, S., E. Oravcová, M Mrázová, et al.. (1997). Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome. Scandinavian Journal of Infectious Diseases. 29(3). 301–304. 16 indexed citations
14.
Špánik, S., J. Trupl, A. Kunová, et al.. (1997). Risk Factors, Aetiology, Therapy and Outcome in 123 Episodes of Breakthrough Bacteraemia and Fungaemia during Antimicrobial Prophylaxis and Therapy in Cancer Patients. Journal of Medical Microbiology. 46(6). 517–523. 17 indexed citations
15.
Kukučková, E., S. Špánik, E. Oravcová, et al.. (1996). Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Supportive Care in Cancer. 4(6). 427–434. 3 indexed citations
16.
Špánik, S., et al.. (1996). Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.. PubMed. 43(4). 235–8. 11 indexed citations
17.
Pichňa, P., E. Oravcová, S. Špánik, et al.. (1996). Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes. International Journal of Antimicrobial Agents. 7(2). 101–107. 3 indexed citations
18.
Trupl, J., A. Kunová, S. Špánik, et al.. (1996). Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.. PubMed. 97(11). 647–51. 8 indexed citations
19.
Oravcová, E., Veronika Bachanová, E. Kukučková, et al.. (1996). Vancomycin plus Imipenem, Ceftazidime or Ciprofloxacin in Second Line Therapy in Patients with Febrile Neutropenia Not Responding to First Line Therapy. Chemotherapy. 42(2). 146–149. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Perego Breakdown of academic impact, for papers by B.A. Oppenheim Breakdown of academic impact, for papers by C. Santini Breakdown of academic impact, for papers by José Luís López-Hontangas Breakdown of academic impact, for papers by E. Kukučková Breakdown of academic impact, for papers by E. Biraghi Breakdown of academic impact, for papers by Alice G. Bergman Breakdown of academic impact, for papers by Asia Obman Breakdown of academic impact, for papers by Essam Girgawy Breakdown of academic impact, for papers by Christine Bonnal
Rankless by CCL
2026